Literature DB >> 19520823

Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?

Bipin N Savani, Paula R Pohlmann, Madan Jagasia, Wichai Chinratanalab, Adetola Kassim, Brian Engelhardt, John Greer, Friedrich Schuening, Stacey Goodman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19520823     DOI： 10.1182/blood-2009-04-213892

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.

Authors:  Wichai Chinratanalab; Nishitha Reddy; John P Greer; David Morgan; Brian Engelhardt; Adetola Kassim; Stephen J Brandt; Madan Jagasia; Stacey Goodman; Bipin N Savani
Journal:  Exp Hematol       Date:  2012-01-21       Impact factor: 3.084

Review 2.  Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.

Authors:  Nishitha Reddy; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-11       Impact factor: 5.742

Review 3.  Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Authors:  Nishitha Reddy; Katayoun Rezvani; A John Barrett; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2010-08-21       Impact factor: 5.742

4.  Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.

Authors:  Mieko Toyoda; Bong-Ha Shin; Shili Ge; James Mirocha; David Thomas; Maggie Chu; Edgar Rodriguez; Christine Chao; Anna Petrosyan; Odette A Galera; Ashley Vo; Jua Choi; Alice Peng; Joseph Kahwaji; Stanley C Jordan
Journal:  J Immunol Res       Date:  2017-02-06       Impact factor: 4.818

5.  Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT.

Authors:  D M Burns; S Rana; E Martin; S Nagra; J Ward; H Osman; A I Bell; P Moss; N H Russell; C F Craddock; C P Fox; S Chaganti
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483

Review 6.  Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives.

Authors:  Francesca Compagno; Sabrina Basso; Arianna Panigari; Jessica Bagnarino; Luca Stoppini; Alessandra Maiello; Tommaso Mina; Paola Zelini; Cesare Perotti; Fausto Baldanti; Marco Zecca; Patrizia Comoli
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

7.  An Unusual Cause of Acute Pancreatitis in a Liver Transplant Recipient.

Authors:  Imran Nizamuddin; Themistoklis Kourkoumpetis; Cecil G Wood; Josh Levitsky
Journal:  Transplant Direct       Date:  2021-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.